2026 Annual Meeting | S5 - Clinical Epilepsy
Program Materials Program Evaluations
| David E. Burdette, MD | Dr. Burdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Burdette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Burdette has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Burdette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life pharmaceuticals. Dr. Burdette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for NeuroPace. Dr. Burdette has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Burdette has received research support from Longboard. The institution of Dr. Burdette has received research support from NeuroPace. |
| Rajsekar R. Rajaraman, MD | Dr. Rajaraman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Marinus Pharmacueticals. |
| Yasho C. Gondi, MD, MBBS | Dr. Gondi has nothing to disclose. |
| Martha Morrell, MD, FAAN | Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has or had stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health. |
| Elizabeth Thiele, MD | Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care. |
| Dipali P. Nemade, MD | Dr. Nemade has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. |
| Najla Dickson, MD | Dr. Dickson has nothing to disclose. |
| Ahmad T. Abdelhak, Student | Mr. Abdelhak has nothing to disclose. |
| Mohanad Ahmad, DO | Dr. Ahmad has nothing to disclose. |
| Hassan Souidan, MD | Dr. Souidan has nothing to disclose. |
| Hussain Shallwani, MBBS | Dr. Shallwani has nothing to disclose. |
| Nathaniel Cho, BS | Mr. Cho has nothing to disclose. |
| Farah Abdelhak | Farah Abdelhak has nothing to disclose. |
| Taha Ataya, MD | Dr. Ataya has nothing to disclose. |
| Orrin Devinsky, MD, FAAN | Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care. |
| Jonathan Kleen, MD, PhD | Dr. Kleen has nothing to disclose. |
| Petrus J. de Vries, MBChB, FRCPsych, PhD | The institution of Prof. de Vries has received research support from National Institute of Mental Health. The institution of Prof. de Vries has received research support from U.S. Department of Defense. Prof. de Vries has a non-compensated relationship as a Consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. |
| Margil Ranpariya, MBBS | Dr. Ranpariya has nothing to disclose. |
| Angela N. Crudele, MD | The institution of Dr. Crudele has received research support from Neuropace. The institution of Dr. Crudele has received research support from Rapport Pharmaceuticals . |
| Gurleen Kaur, MD | Dr. Kaur has nothing to disclose. |
| Yoonhyuk Jang, MD, PhD | Mr. Jang has nothing to disclose. |
| Lisa Moore-Ramdin, MBBS | Dr. Moore-Ramdin has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Moore-Ramdin has stock in Jazz Pharmaceuticals. |
| Patrick Landazuri, MD, FAAN | Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care. |
| Ankith Bhasi, MD, DM | Dr. Bhasi has nothing to disclose. |
| Agnies van Eeghen, PhD | The institution of Dr. van Eeghen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals . The institution of Dr. van Eeghen has received research support from jazz pharmaceuticals . The institution of Dr. van Eeghen has received research support from ForWishdoem . The institution of Dr. van Eeghen has received research support from European Commission / ERN ITHACA . |
| Benedict Yeoh | Mr. Yeoh has received personal compensation for serving as an employee of Vanderbilt University Medical Center. |
| Soon-Tae Lee, MD, PhD | Prof. Lee has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Piehealthcare. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salted. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Prof. Lee has received research support from Roche. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care. |
| Kanokwan Boonyapisit, MD | Dr. Boonyapisit has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for The Neurological Society of Thailand. Dr. Boonyapisit has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for The Epilepsy Society of Thailand. |
| Zahir Arrayeh | Zahir Arrayeh has nothing to disclose. |
| Ramshekhar N. Menon, MD, MBBS, DM; PDF | Dr. MENON has nothing to disclose. |
| Renzo Guerrini | Renzo Guerrini has nothing to disclose. |
| Ashalatha Radhakrishnan, Sr., MD | Dr. Radhakrishnan has nothing to disclose. |
| Joanne Stevens, BA | Ms. Stevens has stock in Jazz Pharmaceuticals. |
| Eric D. Marsh, MD, PhD | Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape. |
| Rhonda Trousdale, MD | The institution of Dr. Trousdale has received research support from NIH. |
| Joseph Sullivan, MD | Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sullivan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Sullivan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Various firms. Dr. Sullivan has stock in Harmony. |
| Bharanidharan Gurumurthy, MD, DM | Dr. Gurumurthy has nothing to disclose. |
| maria dunaway-Bryant, Director of Clinical Operation | Mrs. dunaway-Bryant has received personal compensation for serving as an employee of Jazz Pharmaceutical Company . |
| Ayush Gupta, MD | Dr. Gupta has nothing to disclose. |
| Karen C. Keough, MD | Dr. Keough has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with UCB. Dr. Keough has received personal compensation in the range of $50,000-$99,999 for serving as a Speaker with Jazz Pharmaceuticals. Dr. Keough has received personal compensation in the range of $50,000-$99,999 for serving as a Speaker with SKLSI . Dr. Keough has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with LivaNova. |
| Yong Eun, MD | Dr. Eun has nothing to disclose. |
| Sarah L. Wilson, MD | Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. |
| Kasia Wajer, BSC , MSc | Miss Wajer has received personal compensation for serving as an employee of Jazz Pharmaceuticals . Miss Wajer has stock in Jazz Pharmaceuticals. |
| Da Zhang, PhD | The institution of Ms. Zhang has received research support from American Epilepsy Society. |
| Vasinee Viarasilpa, MD | Dr. Viarasilpa has nothing to disclose. |
| Imani Evans | No disclosure on file |
| Anutr Khummongkol, MD | Mr. Khummongkol has nothing to disclose. |
| Brian P. Kilgallen | Mr. Kilgallen has received personal compensation for serving as an employee of UCB. Mr. Kilgallen has stock in UCB. |
| Peter St. Wecker, PhD | Dr. St. Wecker has received personal compensation for serving as an employee of UCB. Dr. St. Wecker has received personal compensation for serving as an employee of Zogenix, Inc.. Dr. St. Wecker has stock in Zogenix. |
| Colin Riley | Mr. Riley has nothing to disclose. |
| Mona Elsayed, MD | Dr. Elsayed has nothing to disclose. |
| Amanda Jaksha, BS | Ms. Jaksha has nothing to disclose. |
| Omar Hage-Hassan, DO | Dr. Hage-Hassan has nothing to disclose. |
| Sam Amin, PhD | Sam Amin has nothing to disclose. |
| Devon Krish | Mr. Krish has nothing to disclose. |
| Domenica I. Battaglia, MD, PhD | Prof. Battaglia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Prof. Battaglia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB-Pharma. Prof. Battaglia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB-Pharma. The institution of Prof. Battaglia has received research support from Italian Minister of University and Scientific Research. |
| Diem H. Tran, PhD | Ms. Tran has nothing to disclose. |
| Leon A. Weinstock, MD | Dr. Weinstock has nothing to disclose. |
| Brooke Onwenu, MD | Brooke Onwenu has nothing to disclose. |
| Hyunyong Koh, MD, PhD | Dr. Koh has nothing to disclose. |
| Sattawut Wongwiangjunt, MD | Dr. Wongwiangjunt has nothing to disclose. |
| Nicola Specchio | Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for stoke. |
| Teresa Greco | Teresa Greco has nothing to disclose. |
| RYOKO HONDA, MD, PhD | Mrs. HONDA has received research support from UCB Inc.. |
| Maria J. Bruzzone, MD, FAAN | Dr. Bruzzone has nothing to disclose. |
| Suhwan Bong | Mr. Bong has nothing to disclose. |
| Gia Melikishivili | No disclosure on file |
| Stevie Roszkowski, PhD | Dr. Roszkowski has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Roszkowski has stock in Jazz Pharmaceuticals. |
| Brian D. Moseley, MD | Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB. |
| Theeradej Tepkasetkul, MD | Dr. Tepkasetkul has nothing to disclose. |
| Shawniqua Williams Roberson, MD | Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. The institution of Dr. Williams Roberson has received research support from the National Institute on Aging. The institution of Dr. Williams Roberson has received research support from Brain & Behavior Research Foundation. The institution of Dr. Williams Roberson has received research support from National Institute on Mental Health . The institution of Dr. Williams Roberson has received research support from Ceribell, Inc.. Dr. Williams Roberson has received personal compensation in the range of $500-$4,999 for serving as a Visiting Speaker with University of Toronto. |
| Angel Aledo-Serrano | Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke pharma. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharma. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. |
| Terra Lee | Ms. Lee has nothing to disclose. |
| Ping Li, MD | Dr. Li has nothing to disclose. |
| Robert L. Glover, MD | Dr. Glover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. Dr. Glover has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Livanova. Dr. Glover has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. |
| Zubia Iqbal, MD | Dr. Iqbal has nothing to disclose. |